CMAC has been awarded circa $1m from the SAVI seed fund including £248K from EPSRC over 3years to support the International Institute for Advanced Pharmaceutical Manufacturing. This is a joint US – UK institute that will bring together world-leading academic expertise to deliver new end-to-end continuous manufacturing capabilities that will transform global supply chain for medicines.

The programme will leverage existing investment in the US and UK, to support an international manufacturing research community. The institute will also engage with regulators to focus research on key targets areas that will maximise impact for end users.